Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004–2011
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective This study used the Medical Expenditures Panel Survey (MEPS) to estimate the cost of diabetes, depression, and comorbid diabetes and depression over 8 years. Methods An 8-year pooled dataset was created using the household and medical provider components of MEPS. Medical expenditures were adjusted to a common 2014 dollar value. Analyses used responses of 147,095 individuals ≥18 years of age for the years 2004–2011. The dependent variable in this study was total healthcare expenditure and the primary independent variables were diabetes and depression status. A two-part (probit/GLM) model was used to estimate the annual medical spending and marginal effects were calculated for incremental cost. Results In the pooled sample, after adjusting for socio-demographic factors, comorbidities and time trend covariates, the incremental cost of depression only was $2,654 (95% CI 2,343–2,966), diabetes was $2,692 (95% CI 2,338–3,046), and both was $6,037 (CI 95% 5,243–6,830) when compared to patients with none. Based on the unadjusted mean, annual average aggregate cost of depression only was estimated at $238.3 billion, diabetes only $150.1 billion and depression and diabetes together was $77.6 billion. Conclusion Costs at both the individual and aggregate level are significant, with comorbid diagnoses resulting in higher incremental costs than the sum of the costs for each diagnosis alone. In addition, while the cost of depression increased over time, the cost of diabetes decreased over time, much due to decreased inpatient costs. This study highlights the tremendous cost savings possible through more aggressive screening, diagnosis, and treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“Diabetes and depression are highly prevalent, with 11% of those with diabetes diagnosed with major depression (Anderson et al., 2001).”
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465 · cited 2×
“5 times higher than patients who are not depressed, with costs increasing as depressive symptom severity increased (Kalsekar et al., 2006; Egede et al., 2002; Ciechanowski et al., 2000).”
InfluentialEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Egede, L. E., Zheng, D., & Simpson, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.464 · Cited by 816 · cited 2×
“5 times higher than patients who are not depressed, with costs increasing as depressive symptom severity increased (Kalsekar et al., 2006; Egede et al., 2002; Ciechanowski et al., 2000).”
InfluentialSelf-citationComparisons of methods for multiple hypothesis testing in neuropsychological research
Blakesley, R. E., Mazumdar, S., Dew, M. A., Houck, P. R., Tang, G., Reynolds, C. F., & Butters, M. A. (2009) · Neuropsychology · doi:10.1037/a0012850 · Cited by 206 · cited 1×
“Standard pairwise comparison methods of Sidak, Scheffe, Bonferroni and Tukey were used to compare the pooled unadjusted total mean expenditures among none, depression only, diabetes only, and depression/diabetes categories (Blakesley et al., 2009; Azkaya and Ercan, 2012).”
Hutter, N., Schnurr, A., & Baumeister, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1873-y · Cited by 155 · cited 1×
“Economic burden includes increased hospitalization, outpatient visits, emergency department visits, and medication costs (Hutter et al., 2010; Le et al., 2006; Finkenstein et al., 2003; Nichols et al., 2007).”
Cited by
Sarda, A., Munuswamy, S., Sarda, S., & Subramanian, V. (2019) · JMIR mHealth and uHealth · doi:10.2196/11041 · Cited by 56
Clarke, J., Sanatkar, S., Baldwin, P. A., Fletcher, S., Gunn, J., Wilhelm, K., Campbell, L., Zwar, N., Harris, M., Lapsley, H., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/12246 · Cited by 52
Clinical specificity profile for novel rapid acting antidepressant drugs
Scala, M., Fanelli, G., De Ronchi, D., Serretti, A., & Fabbri, C. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000488 · Cited by 41
Metadata
- Authors
- Egede, L. E., Bishu, K. G., Walker, R. J., & Dismuke, C. E.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 195
- Pages
- 119-126
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2265316152
- Cited by
- 83
- References
- 11
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.